The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma

M. J. Overman, L. Feng, B. Pro, P. McLaughlin, M. Hess, F. Samaniego, A. Younes, J. E. Romaguera, F. B. Hagemeister, L. Kwak, F. Cabanillas, M. A. Rodriguez, L. E. Fayad*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences